CoChat
Sign Up
Cited by 315

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Effects of engineered nanoparticles on the innate immune system

Liu, Yuanchang, Hardie, Joseph, Zhang, Xianzhi, Rotello, Vincent M.·2017·Seminars in Immunology
DOI 10.1016/j.smim.2017.09.011PMC PMC5705289
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.smim.2017.09.011

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 104

  1. Zhang, 2008, Nanoparticles in medicine therapeutic applications and developments, Clin. Pharmacol. Ther., 83, 761, 10.1038/sj.clpt.6100400 · DOI
  2. Kamyshny, 2014, Conductive nanomaterials for printed electronics, Small, 10, 3515, 10.1002/smll.201303000 · DOI
  3. Ssneha, 2014, Application of nanotechnology in dentistry, Res. J. Pharm. Technol., 7, 81
  4. Dastjerdi, 2010, A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties, Colloids Surf. B Biointerfaces, 79, 5, 10.1016/j.colsurfb.2010.03.029 · DOI
  5. Dobrovolskaia, 2016, Current understanding of interactions between nanoparticles and the immune system, Toxicol. Appl. Pharmacol., 299, 78, 10.1016/j.taap.2015.12.022 · DOI
  6. Kreitinger, 2016, Environmental immunology lessons learned from exposure to a select panel of immunotoxicants, J. Immunol., 196, 3217, 10.4049/jimmunol.1502149 · DOI
  7. Petrarca, 2015, Engineered metal based nanoparticles and innate immunity, Clin. Mol. Allergy, 13, 13, 10.1186/s12948-015-0020-1 · DOI
  8. Kononenko, 2015, Nanoparticle interaction with the immune system, Arch. Ind. Hyg. Toxicol., 66, 97
  9. Shimizu, 2014, Effect of maternal exposure to carbon black nanoparticle during early gestation on the splenic phenotype of neonatal mouse, J. Toxicol. Sci., 39, 571, 10.2131/jts.39.571 · DOI
  10. Vivier, 2005, Innate and adaptive immunity: specificities and signaling hierarchies revisited, Nat. Immunol., 6, 17, 10.1038/ni1153 · DOI
  11. Luo, 2015, Metal-based nanoparticles and the immune system: activation, inflammation, and potential applications, BioMed Res. Int., 2015
  12. Palucka, 2012, Cancer immunotherapy via dendritic cells, Nat. Rev. Cancer, 12, 265, 10.1038/nrc3258 · DOI
  13. Shao, 2015, Nanoparticle-based immunotherapy, ACS Nano, 9, 16, 10.1021/nn5062029 · DOI
  14. Fievez, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach, J. Controlled Release, 116, 1, 10.1016/j.jconrel.2006.08.013 · DOI · Paper page
  15. Peek, 2008, Nanotechnology in vaccine delivery, Adv. Drug Deliv. Rev., 60, 915, 10.1016/j.addr.2007.05.017 · DOI
  16. Smith, 2013, Applications of nanotechnology for immunology, Nat. Rev. Immunol., 13, 592, 10.1038/nri3488 · DOI
  17. Irvine, 2015, Synthetic nanoparticles immunotherapy, Chem. Rev., 115, 11109, 10.1021/acs.chemrev.5b00109 · DOI
  18. Zhao, 2014, Nanoparticle vaccines, Vaccine, 32, 327, 10.1016/j.vaccine.2013.11.069 · DOI
  19. Szeto, 2016, Materials design at the interface of nanoparticles and innate immunity, J. Mater. Chem. B Mater. Biol. Med., 4, 1610, 10.1039/C5TB01825K · DOI
  20. Sarma, 2011, The complement system, Cell Tissue Res., 227, 10.1007/s00441-010-1034-0 · DOI
  21. Najafi-Hajivar, 2016, Overview on experimental models of interactions between nanoparticles and the immune system, Biomed. Pharmacother., 83, 1365, 10.1016/j.biopha.2016.08.060 · DOI
  22. Coyne, 2012, PAMPs and DAMPs: signal 0s that spur autophagy and immunity, Immunol. Rev., 249, 158, 10.1111/j.1600-065X.2012.01146.x · DOI
  23. Landesman-Milo, 2012, Altering the immune response with lipid-based nanoparticles, J. Controlled Release, 161, 600, 10.1016/j.jconrel.2011.12.034 · DOI
  24. Moyano, 2016, Modulation of immune response using engineered nanoparticle surfaces, Small, 12, 76, 10.1002/smll.201502273 · DOI
  25. Getts, 2015, Harnessing nanoparticles for immune modulation, Trends Immunol., 36, 419, 10.1016/j.it.2015.05.007 · DOI
  26. Oh, 2014, Endocytosis and exocytosis of nanoparticles in mammalian cells, Int. J. Nanomed., 9, 51
  27. Ning, 2011, The internalization pathway, metabolic fate and biological effect of superparamagnetic iron oxide nanoparticles in the macrophage-like RAW264.7 cell, Sci. China Life Sci., 54, 793, 10.1007/s11427-011-4215-5 · DOI
  28. Kuhn, 2014, Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages, Beilstein J. Nanotechnol., 5, 1625, 10.3762/bjnano.5.174 · DOI
  29. Tomić, 2014, Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro, PLoS One, 9, 1, 10.1371/journal.pone.0096584 · DOI
  30. Oh, 2010, Cytotoxicity, and innate immune response of silica – titania hollow nanoparticles based on size and surface functionality, ACS Nano, 4, 5301, 10.1021/nn100561e · DOI
  31. Kim, 2011, Cytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cells, Biomaterials, 32, 2342, 10.1016/j.biomaterials.2010.11.080 · DOI
  32. Hirn, 2011, Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration, Eur. J. Pharm. Biopharm., 77, 407, 10.1016/j.ejpb.2010.12.029 · DOI
  33. Sonavane, 2008, Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size, Colloids Surf. B Biointerfaces, 66, 274, 10.1016/j.colsurfb.2008.07.004 · DOI
  34. Manolova, 2008, Nanoparticles target distinct dendritic cell populations according to their size, Eur. J. Immunol., 38, 1404, 10.1002/eji.200737984 · DOI
  35. Mostaghaci, 2015, Transfection system of amino-functionalized calcium phosphate nanoparticles: in vitro efficacy, biodegradability, and immunogenicity study, ACS Appl. Mater. Interfaces, 7, 5124, 10.1021/am507193a · DOI
  36. Sun, 2013, Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles, ACS Nano, 7, 10834, 10.1021/nn404211j · DOI
  37. K.W. Leong, H.S. Yoo, J., Accepted, Multi-Functional Nanorods Serving as Nano- Bridges to Modulate T Cell-Mediated Immunity, (2013) 9771–9779. · DOI
  38. Wibroe, 2017, Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes, Nat. Nanotechnol., 12, 589, 10.1038/nnano.2017.47 · DOI
  39. Talamini, 2017, Influence of size and shape on the anatomical distribution of endotoxin-free gold nanoparticles, ACS Nano, 11, 5519, 10.1021/acsnano.7b00497 · DOI
  40. Schanen, 2009, Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct, ACS Nano, 3, 2523, 10.1021/nn900403h · DOI
  41. Doshi, 2010, Macrophages recognize size and shape of their targets, PLoS One, 5, 1, 10.1371/journal.pone.0010051 · DOI
  42. Gause, 2017, Immunological principles guiding the rational design of particles for vaccine delivery, ACS Nano, 11, 54, 10.1021/acsnano.6b07343 · DOI
  43. Liu, 2013, Surface hydrophobicity of microparticles modulates adjuvanticity, J. Mater. Chem. B., 1, 3888, 10.1039/c3tb20383b · DOI
  44. Moyano, 2012, Nanoparticle hydrophobicity dictates immune response, J. Am. Chem. Soc., 1
  45. Saha, 2016, Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona, ACS Nano, 10, 4421, 10.1021/acsnano.6b00053 · DOI
  46. Moyano, 2014, Fabrication of corona free nanoparticles with tunable hydrophobicity, ACS Nano, 8, 6748, 10.1021/nn5006478 · DOI
  47. Moyano, 2016, Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems, Chemistry, 1, 320, 10.1016/j.chempr.2016.07.007 · DOI
  48. Jiang, 2017, Designing nanomedicine for immuno-oncology, Nat. Biomed. Eng., 1, 29, 10.1038/s41551-017-0029 · DOI
  49. Chen, 2016, Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo, Nat. Nanotechnol., 12, 387, 10.1038/nnano.2016.269 · DOI · Paper page
  50. Walkey, 2014, Protein corona fingerprinting predicts the cellular interactions of gold and silver nanoparticles, ACS Nano, 8, 2439, 10.1021/nn406018q · DOI
  51. Schöttler, 2016, Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers, Nat. Nanotechnol., 11, 372, 10.1038/nnano.2015.330 · DOI · Paper page
  52. Larson, 2012, Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield, ACS Nano, 6, 9182, 10.1021/nn3035155 · DOI
  53. Kwon, 2005, Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles, J. Controlled Release, 105, 199, 10.1016/j.jconrel.2005.02.027 · DOI
  54. Fytianos, 2017, Aerosol delivery of functionalized gold nanoparticles target and activate dendritic cells in a 3D lung cellular model, ACS Nano, 11, 375, 10.1021/acsnano.6b06061 · DOI
  55. Xu, 2016, The responses of immune cells to iron oxide nanoparticles, J. Appl. Toxicol., 36, 543, 10.1002/jat.3282 · DOI
  56. Mou, 2017, The effect of superparamagnetic iron oxide nanoparticle surface charge on antigen cross-presentation, Nanoscale Res. Lett., 12, 52, 10.1186/s11671-017-1828-z · DOI
  57. Lunov, 2011, Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line, ACS Nano, 5, 1657, 10.1021/nn2000756 · DOI
  58. Fromen, 2016, Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells nanomedicine nanotechnology, Biol. Med., 12, 677
  59. Moser, 2017, Surface coating of nanoparticles reduces background inflammatory activity while increasing particle uptake and delivery, ACS Biomater. Sci. Eng., 3, 206, 10.1021/acsbiomaterials.6b00473 · DOI
  60. Liu, 2015, CD47 blockade triggers T cell −mediated destruction of immunogenic tumors, Nat. Med., 21, 1209, 10.1038/nm.3931 · DOI
  61. Qie, 2016, Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes, Sci. Rep., 6, 26269, 10.1038/srep26269 · DOI
  62. Siefert, 2016, Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy, Biomaterials, 97, 85, 10.1016/j.biomaterials.2016.03.039 · DOI
  63. Hernández-Gil, 2015, An iron oxide nanocarrier loaded with a Pt(IV) prodrug and immunostimulatory dsRNA for combining complementary cancer killing effects, Adv. Healthc. Mater., 4, 1034, 10.1002/adhm.201500080 · DOI
  64. Weilhammer, 2013, The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge, Biomaterials, 34, 10305, 10.1016/j.biomaterials.2013.09.038 · DOI
  65. Petersen, 2011, Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants, Biomaterials, 32, 6815, 10.1016/j.biomaterials.2011.05.063 · DOI
  66. Camacho, 2011, Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators, Vaccine, 29, 7130, 10.1016/j.vaccine.2011.05.072 · DOI
  67. Foit, 2016, Biomaterials Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding toll-like receptor 4, Biomaterials, 100, 67, 10.1016/j.biomaterials.2016.05.021 · DOI
  68. Belling, 2016, Stealth immune properties of graphene oxide enabled by surface-bound complement factor H, ACS Nano, 10, 10161, 10.1021/acsnano.6b05409 · DOI
  69. Yu, 2014, Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry, ACS Nano, 8, 7687, 10.1021/nn504186b · DOI
  70. Tarasova, 2017, Cytotoxic and proinflammatory effects of metal-based nanoparticles on THP-1 monocytes characterized by combined proteomics approaches, J. Proteome Res., 16, 689, 10.1021/acs.jproteome.6b00747 · DOI
  71. Giovanni, 2015, Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver titanium dioxide, and zinc oxide nanoparticles, J. Hazard. Mater., 297, 146, 10.1016/j.jhazmat.2015.04.081 · DOI
  72. Fang, 2015, Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy, Small, 11, 5483, 10.1002/smll.201501284 · DOI
  73. Gomes, 2017, Harnessing nanoparticles for immunomodulation and vaccines, Vaccines, 5, 6, 10.3390/vaccines5010006 · DOI
  74. Ilinskaya, 2014, Immunosuppressive and anti-inflammatory properties of engineered nanomaterials, Br. J. Pharmacol., 171, 3988, 10.1111/bph.12722 · DOI
  75. Xie, 2017, Immune cell-Mediated biodegradable theranostic nanoparticles for melanoma targeting and drug delivery, Small, 13, 1603121, 10.1002/smll.201603121 · DOI
  76. Pitt, 2014, Dendritic cell-Derived exosomes as immunotherapies in the fight against cancer, J. Immunol., 193, 1006, 10.4049/jimmunol.1400703 · DOI
  77. De La, 2009, Artificial exosomes as tools for basic and clinical immunology, J. Immunol. Methods, 344, 121, 10.1016/j.jim.2009.03.011 · DOI
  78. Parodi, 2012, Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions, Nat. Nanotechnol., 8, 61, 10.1038/nnano.2012.212 · DOI
  79. Cho, 2011, A multifunctional core−shell nanoparticle for dendritic cell-based cancer immunotherapy, Nat. Nanotechnol., 6, 675, 10.1038/nnano.2011.149 · DOI · Paper page
  80. Zanganeh, 2016, Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues, Nat. Nanotechnol., 11, 986, 10.1038/nnano.2016.168 · DOI · Paper page
  81. Suzuki, 2009, A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy, J. Control. Release., 133, 198, 10.1016/j.jconrel.2008.10.015 · DOI
  82. Unga, 2014, Ultrasound induced cancer immunotherapy, Adv. Drug Deliv. Rev., 72, 144, 10.1016/j.addr.2014.03.004 · DOI
  83. Sano, 2013, Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors, ACS Nano, 7, 717, 10.1021/nn305011p · DOI
  84. Xiang, 2015, Antigen-loaded upconversion nanoparticles for dendritic cell stimulation, tracking, and vaccination in dendritic cell-based immunotherapy, ACS Nano, 9, 6401, 10.1021/acsnano.5b02014 · DOI
  85. Warashina, 2016, A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells, J. Controlled Release, 225, 183, 10.1016/j.jconrel.2016.01.042 · DOI
  86. Das, 2008, Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells, J. Biomed. Mater. Res. − Part A., 85, 983, 10.1002/jbm.a.31557 · DOI
  87. Nadig, 2015, Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity, RSC Adv., 5, 43552, 10.1039/C5RA04057D · DOI
  88. Pan, 2015, Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats, J. Controlled Release, 201, 32, 10.1016/j.jconrel.2015.01.009 · DOI
  89. Lee, 2014, Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis, ACS Nano, 8, 4790, 10.1021/nn500685h · DOI
  90. Halwani, 2016, A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma, Exp. Mol. Med., 48, e262, 10.1038/emm.2016.89 · DOI
  91. He, 2016, Suppression of hepatic inflammation via systemic siRNA delivery by membrane-disruptive and endosomolytic helical polypeptide hybrid nanoparticles, ACS Nano, 10, 1859, 10.1021/acsnano.5b05470 · DOI
  92. Park, 2012, The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis, Biomaterials, 33, 8600, 10.1016/j.biomaterials.2012.08.008 · DOI
  93. Leuschner, 2011, Therapeutic siRNA silencing in inflammatory monocytes in mice, Nat. Biotechnol., 29, 1005, 10.1038/nbt.1989 · DOI · Paper page
  94. Heydarnejad, 2014, Sliver nanoparticles accelerate skin wound healing in mice (Mus musculus) through suppression of innate immune system, Nanomed. J., 1, 79
  95. Pedata, 2016, Immunotoxicological impact of occupational and environmental nanoparticles exposure: the influence of physical, chemical, and combined characteristics of the particles, Int. J. Immunopathol. Pharmacol., 29, 343, 10.1177/0394632015608933 · DOI
  96. Mahmoudzadeh, 2016, Collagen-chitosan 3-D nano-scaffolds effects on macrophage phagocytosis and pro-inflammatory cytokine release, J. Immunol., 13, 526
  97. Kawabata, 2012, Development of immunotoxicity testing strategies for immunomodulatory drugs, Toxicol. Pathol., 40, 288, 10.1177/0192623311430238 · DOI
  98. Li, 2016, Assessing the immunosafety of engineered nanoparticles with a novel in vitro model based on human primary monocytes, ACS Appl. Mater. Interfaces, 8, 28437, 10.1021/acsami.6b06278 · DOI
  99. Fröhlich, 2015, Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo, Int. J. Nanomed., 10, 3761, 10.2147/IJN.S83068 · DOI
  100. Cheng, 2015, A holistic approach to targeting disease with polymeric nanoparticles, Nat. Rev. Drug Discov., 14, 239, 10.1038/nrd4503 · DOI · Paper page
  101. Mohanan, 2010, Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems, J. Control. Release, 147, 342, 10.1016/j.jconrel.2010.08.012 · DOI
  102. Li, 2017, Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results, Front. Immunol., 8, 1
  103. Vallhov, 2006, The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications, Nano Lett., 6, 1682, 10.1021/nl060860z · DOI
  104. Deville, 2016, Interaction of gold nanoparticles and nickel(II) sulfate affects dendritic cell maturation, J. Nanotoxicol., 10, 1395, 10.1080/17435390.2016.1221476 · DOI

Cited by

Sorted by citations

See all 315

Metadata

Authors
Liu, Y., Hardie, J., Zhang, X., & Rotello, V. M.
Venue
Seminars in Immunology
Publisher
Elsevier BV
Published
2017-12
Volume
34
Pages
25-32
ISSN
1044-5323
DOI
10.1016/j.smim.2017.09.011
PMC
PMC5705289
Cited by
315
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review